Literature DB >> 23428956

Cerebral white matter blood flow and energy metabolism in multiple sclerosis.

Christel Steen1, Miguel D'haeseleer, Johannes M Hoogduin, Yves Fierens, Melissa Cambron, Jop P Mostert, Dorothea J Heersema, Marcus W Koch, Jacques De Keyser.   

Abstract

BACKGROUND: Cerebral blood flow (CBF) is reduced in normal-appearing white matter (NAWM) of subjects with multiple sclerosis (MS), but the underlying mechanism is unknown.
OBJECTIVE: The objective of this article is to assess the relationship between reduced NAWM CBF and both axonal mitochondrial metabolism and astrocytic phosphocreatine (PCr) metabolism.
METHODS: Ten healthy controls and 25 MS subjects were studied with 3 Tesla magnetic resonance imaging. CBF was measured using pseudo-continuous arterial spin labeling. N-acetylaspartate/creatine (NAA/Cr) ratios (axonal mitochondrial metabolism) were obtained using (1)H-MR spectroscopy and PCr/β-ATP ratios using (31)P-MR spectroscopy. In centrum semiovale NAWM, we assessed correlations between CBF and both NAA/Cr and PCr/β-ATP ratios.
RESULTS: Subjects with MS had a widespread reduction in CBF of NAWM (centrum semiovale, periventricular, frontal and occipital), and gray matter (frontoparietal cortex and thalamus). Compared to controls, NAA/Cr in NAWM of the centrum semiovale of MS subjects was decreased, whereas PCr/β-ATP was increased. We found no correlations between CBF and PCr/β-ATP. CBF and NAA/Cr correlated in controls (p = 0.02), but not in MS subjects (p = 0.68).
CONCLUSIONS: Our results suggest that in MS patients there is no relationship between reduced CBF in NAWM and impaired axonal mitochondrial metabolism or astrocytic PCr metabolism.

Entities:  

Keywords:  Multiple sclerosis; N-acetylaspartate; arterial spin labeling; cerebral blood flow; magnetic resonance spectroscopy; phosphocreatine

Mesh:

Substances:

Year:  2013        PMID: 23428956     DOI: 10.1177/1352458513477228

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  13 in total

1.  Impaired retinal microcirculation in multiple sclerosis.

Authors:  Hong Jiang; Silvia Delgado; Jia Tan; Che Liu; Kottil W Rammohan; Delia Cabrera DeBuc; Byron L Lam; William J Feuer; Jianhua Wang
Journal:  Mult Scler       Date:  2016-02-22       Impact factor: 6.312

2.  Brain perfusion by arterial spin labeling MRI in multiple sclerosis.

Authors:  Tatiana Koudriavtseva; Domenico Plantone; Rosaria Renna; Matilde Inglese
Journal:  J Neurol       Date:  2015-05-28       Impact factor: 4.849

3.  Brain perfusion and vasoreactivity in multiple sclerosis.

Authors:  T Koudriavtseva; E Sbardella; C Mainero
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-15       Impact factor: 3.825

4.  Retinal Tissue Perfusion in Patients with Multiple Sclerosis.

Authors:  Yi Liu; Silvia Delgado; Hong Jiang; Ying Lin; Jeffrey Hernandez; Yuqing Deng; Giovana Rosa Gameiro; Jianhua Wang
Journal:  Curr Eye Res       Date:  2019-05-15       Impact factor: 2.424

Review 5.  Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?

Authors:  Miguel D'haeseleer; Stéphanie Hostenbach; Ilse Peeters; Souraya El Sankari; Guy Nagels; Jacques De Keyser; Marie B D'hooghe
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-24       Impact factor: 6.200

6.  Optical Coherence Tomography and Optical Coherence Tomography Angiography Findings in Multiple Sclerosis Patients.

Authors:  Ayşe Balıkçı; Neslihan Parmak Yener; Meral Seferoğlu
Journal:  Neuroophthalmology       Date:  2021-08-20

Review 7.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

8.  Detecting deoxyhemoglobin in spinal cord vasculature of the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis using susceptibility MRI and hyperoxygenation.

Authors:  Nabeela Nathoo; James A Rogers; V Wee Yong; Jeff F Dunn
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

Review 9.  Quantifying the Metabolic Signature of Multiple Sclerosis by in vivo Proton Magnetic Resonance Spectroscopy: Current Challenges and Future Outlook in the Translation From Proton Signal to Diagnostic Biomarker.

Authors:  Kelley M Swanberg; Karl Landheer; David Pitt; Christoph Juchem
Journal:  Front Neurol       Date:  2019-11-15       Impact factor: 4.003

Review 10.  Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in.

Authors:  Jeroen Van Schependom; Kaat Guldolf; Marie Béatrice D'hooghe; Guy Nagels; Miguel D'haeseleer
Journal:  Transl Neurodegener       Date:  2019-12-09       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.